Editorial: Can Glucagon Like Peptide 1 (GLP1) Agonists or Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors Ameliorate Non-Alcoholic Steatohepatitis in People with or without Diabetes?

Author(s): Vasilios G. Athyros, Niki Katsiki, Asterios Karagiannis.

Journal Name: Current Vascular Pharmacology

Volume 14 , Issue 6 , 2016

Become EABM
Become Reviewer

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 14
ISSUE: 6
Year: 2016
Page: [494 - 497]
Pages: 4
DOI: 10.2174/1570161114666160909161811

Article Metrics

PDF: 53